首页> 外国专利> A method for identifying a subset of polynucleotides from a starting amount of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient.

A method for identifying a subset of polynucleotides from a starting amount of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient.

机译:一种用于从起始量的对应于人类基因组的多核苷酸中鉴定多核苷酸的子集的方法,用于体外确定患者宿主反应的严重性。

摘要

The present invention relates to a method for identifying a subset of polynucleotides from a starting amount of polynucleotides corresponding to the human genome for in vitro determination of a severity of host response of a patient in an acute infectious and / or acute inflammatory state in one Wherein a subject is used which comprises a plurality of different gene probes representing the substantially total human genome, the subjects being classified into at least two of the clinically determined phenotype groups according to their status of infection and / or inflammation, the changes in gene expression signals Are statistically compared between the phenotype groups, and such gene probes are selected whose gene expression signals are statistically significantly changed between at least two phenotype groups. A master score is determined as a measure of the severity of the host response, and a number of polynucleotides, which are significantly reduced in comparison to the initial quantity, are identified by determining a score which does not exceed a predetermined deviation from the master score. This score can be used to diagnose, predict the development or monitoring of an acute infectious and / or inflammatory condition of a patient and / or the therapy course control and / or to focus control.
机译:本发明涉及一种用于从起始量的对应于人类基因组的多核苷酸中鉴定多核苷酸的子集的方法,用于在体外确定一个急性感染和/或急性炎症状态下患者的宿主反应的严重性。使用一种受试者,其包含代表基本整个人类基因组的多种不同的基因探针,根据受试者的感染和/或炎症状态,基因表达信号的变化,将受试者分为至少两个临床确定的表型组在表型组之间进行统计学比较,并选择基因表达信号在至少两个表型组之间统计上显着变化的基因探针。确定主分数作为宿主反应严重程度的度量,并且通过确定不超过主分数的预定偏差的分数来识别与初始数量相比显着减少的多核苷酸数量。该分数可以用于诊断,预测患者的急性感染和/或炎症状况和/或治疗过程的控制和/或聚焦控制的发展或监测。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号